As shown in Fig 6B, a series of CDD‐associated mutations severely reduced CDKL5 activity towards ELOA‐pSer311, whereas a series of benign variants did not (Fig 6B). The gene discussed is CDKL5; the disease is craniodiaphyseal dysplasia.